Location History:
- Plainsboro, NJ (US) (1990 - 1991)
- Princeton Junction, NJ (US) (1993 - 2002)
Company Filing History:
Years Active: 1990-2002
Title: Christine E Swenson: Innovator in Liposome Technology
Introduction
Christine E Swenson is a prominent inventor based in Princeton Junction, NJ (US). She has made significant contributions to the field of liposome technology, holding a total of 8 patents. Her work focuses on the development of innovative pharmaceutical compositions that utilize lipid vesicles for various applications.
Latest Patents
One of her latest patents involves the preparation of steroidal liposomes. This invention describes methods and compositions for creating bioactive agents that are entrapped in lipid vesicles. The bilayers of these vesicles comprise a salt form of an organic acid derivative of a sterol, such as the tris-salt form of a sterol hemisuccinate. The compositions also include a mixture of tris(hydroxymethyl)aminomethane salt of cholesteryl hemisuccinate with either an antifungal compound or a peptide. These compositions have various applications in vivo.
Another notable patent by Christine E Swenson provides a composition containing a sized liposome comprising a lipid and an inducer. The sized liposome has a diameter of at most about 1 micron, and the inducer is present in an amount effective to induce interdigitation-fusion of the sized liposome. This invention also includes interdigitation-fusion liposomes and gels, along with methods for their production.
Career Highlights
Christine E Swenson is associated with The Liposome Company, Inc., where she continues to advance her research and innovations in liposome technology. Her work has been instrumental in developing new pharmaceutical formulations that enhance the delivery of therapeutic agents.
Collaborations
Throughout her career, Christine has collaborated with notable colleagues, including Andrew S Janoff and Mircea C Popescu. These collaborations have contributed to the advancement of her research and the successful development of her patented technologies.
Conclusion
Christine E Swenson is a trailblazer in the field of liposome technology, with a strong portfolio of patents that reflect her innovative spirit. Her contributions have the potential to significantly impact pharmaceutical applications and improve therapeutic outcomes.